Differential expression of immune related genes in high-grade ovarian serous carcinoma
Sharareh Siamakpour‐Reihani(Duke University), Angeles Alvarez Secord(Duke University), Kouros Owzar(Duke University), Chen Jiang(University of Hong Kong), Andrew B. Nixon(Duke University), Rebecca A. Previs(LabCorp (United States)), Dadong Zhang(Duke Cancer Institute), Lauren Cobb(The University of Texas MD Anderson Cancer Center)
Cited by 6
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655